Finch Therapeutics Group, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Finch Therapeutics Group, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Finch Therapeutics Group, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$4.83M, a 30.4% increase year-over-year.
  • Finch Therapeutics Group, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$14.2M, a 89.6% increase year-over-year.
  • Finch Therapeutics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$74.8M, a 34.8% increase from 2022.
  • Finch Therapeutics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$115M, a 97.1% decline from 2021.
  • Finch Therapeutics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$58.2M, a 47.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$74.8M +$39.9M +34.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$115M -$56.5M -97.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$58.2M -$18.8M -47.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$39.3M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.